Insider Transactions in Q4 2024 at United Therapeutics Corp (UTHR)
Insider Transaction List (Q4 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 21
2024
|
Paul A Mahon EVP & GENERAL COUNSEL |
SELL
Open market or private sale
|
Direct |
7,700
-17.34%
|
$2,825,900
$367.36 P/Share
|
|
Nov 21
2024
|
Paul A Mahon EVP & GENERAL COUNSEL |
BUY
Exercise of conversion of derivative security
|
Direct |
7,700
+14.78%
|
$1,255,100
$163.3 P/Share
|
|
Nov 18
2024
|
Michael Benkowitz PRESIDENT AND COO |
SELL
Open market or private sale
|
Indirect |
10,000
-50.01%
|
$3,590,000
$359.43 P/Share
|
|
Nov 18
2024
|
Michael Benkowitz PRESIDENT AND COO |
BUY
Exercise of conversion of derivative security
|
Indirect |
10,000
+50.0%
|
$1,060,000
$106.56 P/Share
|
|
Nov 11
2024
|
Judy D. Olian |
SELL
Open market or private sale
|
Direct |
1,750
-23.63%
|
$721,000
$412.48 P/Share
|
|
Nov 11
2024
|
Michael Benkowitz PRESIDENT AND COO |
SELL
Open market or private sale
|
Indirect |
15,000
-41.8%
|
$6,105,000
$407.67 P/Share
|
|
Nov 11
2024
|
Michael Benkowitz PRESIDENT AND COO |
BUY
Exercise of conversion of derivative security
|
Indirect |
15,000
+50.0%
|
$1,590,000
$106.56 P/Share
|
|
Nov 08
2024
|
Nilda Mesa |
SELL
Open market or private sale
|
Direct |
224
-3.73%
|
$92,288
$412.28 P/Share
|
|
Nov 07
2024
|
Michael Benkowitz PRESIDENT AND COO |
SELL
Open market or private sale
|
Indirect |
15,000
-69.36%
|
$6,015,000
$401.57 P/Share
|
|
Nov 07
2024
|
Michael Benkowitz PRESIDENT AND COO |
BUY
Exercise of conversion of derivative security
|
Indirect |
15,000
+50.0%
|
$1,590,000
$106.56 P/Share
|
|
Nov 07
2024
|
Paul A Mahon EVP & GENERAL COUNSEL |
SELL
Sale (or disposition) back to the issuer
|
Direct |
7,700
-17.34%
|
$3,095,400
$402.57 P/Share
|
|
Nov 07
2024
|
Paul A Mahon EVP & GENERAL COUNSEL |
BUY
Exercise of conversion of derivative security
|
Direct |
7,700
+14.78%
|
$1,255,100
$163.3 P/Share
|
|
Nov 06
2024
|
Michael Benkowitz PRESIDENT AND COO |
SELL
Open market or private sale
|
Indirect |
10,000
-44.4%
|
$3,950,000
$395.48 P/Share
|
|
Nov 06
2024
|
Michael Benkowitz PRESIDENT AND COO |
BUY
Exercise of conversion of derivative security
|
Indirect |
10,000
+42.86%
|
$1,110,000
$111.12 P/Share
|
|
Nov 05
2024
|
Richard Giltner |
SELL
Open market or private sale
|
Direct |
10,000
-19.42%
|
$3,810,000
$381.94 P/Share
|
|
Nov 05
2024
|
Richard Giltner |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+26.72%
|
$1,750,000
$175.43 P/Share
|
|
Nov 04
2024
|
James Edgemond CFO AND TREASURER |
SELL
Open market or private sale
|
Direct |
7,778
-18.64%
|
$2,908,972
$374.02 P/Share
|
|
Nov 04
2024
|
James Edgemond CFO AND TREASURER |
BUY
Exercise of conversion of derivative security
|
Direct |
8,334
+16.23%
|
$991,746
$119.01 P/Share
|
|
Nov 01
2024
|
Michael Benkowitz PRESIDENT AND COO |
SELL
Open market or private sale
|
Indirect |
14,700
-46.51%
|
$5,497,800
$374.41 P/Share
|
|
Nov 01
2024
|
Michael Benkowitz PRESIDENT AND COO |
BUY
Exercise of conversion of derivative security
|
Indirect |
14,700
+50.0%
|
$1,764,000
$120.26 P/Share
|
|
Nov 01
2024
|
Christopher Causey |
SELL
Open market or private sale
|
Direct |
510
-12.19%
|
$191,760
$376.63 P/Share
|
|
Oct 28
2024
|
James Edgemond CFO AND TREASURER |
SELL
Open market or private sale
|
Direct |
7,800
-19.73%
|
$2,730,000
$350.0 P/Share
|
|
Oct 28
2024
|
James Edgemond CFO AND TREASURER |
BUY
Exercise of conversion of derivative security
|
Direct |
8,334
+16.96%
|
$991,746
$119.01 P/Share
|
|
Oct 21
2024
|
James Edgemond CFO AND TREASURER |
SELL
Open market or private sale
|
Direct |
7,782
-20.85%
|
$2,848,212
$366.99 P/Share
|
|
Oct 21
2024
|
James Edgemond CFO AND TREASURER |
BUY
Exercise of conversion of derivative security
|
Direct |
8,334
+17.79%
|
$991,746
$119.01 P/Share
|
|
Oct 17
2024
|
Paul A Mahon EVP & GENERAL COUNSEL |
SELL
Sale (or disposition) back to the issuer
|
Direct |
7,700
-17.34%
|
$2,864,400
$372.81 P/Share
|
|
Oct 17
2024
|
Paul A Mahon EVP & GENERAL COUNSEL |
BUY
Exercise of conversion of derivative security
|
Direct |
7,700
+14.78%
|
$1,255,100
$163.3 P/Share
|
|
Oct 14
2024
|
James Edgemond CFO AND TREASURER |
SELL
Open market or private sale
|
Direct |
7,792
-22.19%
|
$2,766,160
$355.88 P/Share
|
|
Oct 14
2024
|
James Edgemond CFO AND TREASURER |
BUY
Exercise of conversion of derivative security
|
Direct |
8,334
+18.7%
|
$1,116,756
$134.01 P/Share
|
|
Oct 07
2024
|
James Edgemond CFO AND TREASURER |
SELL
Open market or private sale
|
Direct |
7,794
-23.67%
|
$2,766,870
$355.54 P/Share
|
|
Oct 07
2024
|
James Edgemond CFO AND TREASURER |
BUY
Exercise of conversion of derivative security
|
Direct |
8,334
+19.71%
|
$991,746
$119.01 P/Share
|
|
Oct 03
2024
|
Paul A Mahon EVP & GENERAL COUNSEL |
SELL
Sale (or disposition) back to the issuer
|
Direct |
7,700
-17.34%
|
$2,695,000
$350.07 P/Share
|
|
Oct 03
2024
|
Paul A Mahon EVP & GENERAL COUNSEL |
BUY
Exercise of conversion of derivative security
|
Direct |
7,700
+14.78%
|
$1,255,100
$163.3 P/Share
|